Download PDF
Z Gastroenterol 2009; 47(10): 1069-1074
DOI: 10.1055/s-0028-1109641
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Chronisch entzündliche Darmerkrankungen und Schwangerschaft

Inflammatory Bowel Disease and PregnancyB. Siegmund1 , M. Zeitz1
  • 1Medizinische Klinik I, Charité, CBF
Further Information

Publication History

Manuskript eingetroffen: 1.3.2009

Manuskript akzeptiert: 7.6.2009

Publication Date:
06 October 2009 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Chronisch entzündliche Darmerkrankungen betreffen viele junge Menschen, die mitten in der Familienplanung stehen. Unsicherheit bei den Betroffenen aber auch bei den betreuenden Ärzten bez. des Krankheitsverlaufs, Medikamentengabe während der Schwangerschaft führt häufig zu einer Entscheidung gegen die Schwangerschaft. Mit der vorliegenden Übersicht soll auf diese Punkte eingegangen und aufgezeigt werden, dass eine chronisch entzündliche Darmerkrankung in der Regel kein Hindernis bei der Familienplanung darstellen sollte.

Abstract

Inflammatory bowel disease (IBD) affects mainly young people who are often in the process of family planning. Insecurity of patients and their primary physicians concerning the disease course and the appropriate medication is often followed by a decision against the pregnancy. With this overview these central issues will be discussed and practical guidelines will be provided, thus encouraging both sides, that IBD and pregnancy is compatible.

Schlüsselwörter

Colitis ulcerosa - Morbus Crohn - chronisch entzündliche Darmerkrankung

Key words

ulcerative colitis - Crohn’s disease - inflammatory bowel disease

Literatur

  • 1 Baird D D, Narendranathan M, Sandler R S. Increased risk of preterm birth for women with inflammatory bowel disease.  Gastroenterology. 1990;  99 987-994
    Google Scholar
  • 2 Timmer A, Bauer A, Dignass A. et al . Sexual function in persons with inflammatory bowel disease: a survey with matched controls.  Clin Gastroenterol Hepatol. 2007;  5 87-94
    Google Scholar
  • 3 Narendranathan M, Sandler R S, Suchindran C M. et al . Male infertility in inflammatory bowel disease.  J Clin Gastroenterol. 1989;  11 403-406
    Google Scholar
  • 4 Johnson P, Richard C, Ravid A. et al . Female infertility after ileal pouch-anal anastomosis for ulcerative colitis.  Dis Colon Rectum. 2004;  47 1119-1126
    Google Scholar
  • 5 Olsen K O, Joelsson M, Laurberg S. et al . Fertility after ileal pouch-anal anastomosis in women with ulcerative colitis.  Br J Surg. 1999;  86 493-495
    Google Scholar
  • 6 Hudson M, Flett G, Sinclair T S. et al . Fertility and pregnancy in inflammatory bowel disease.  Int J Gynaecol Obstet. 1997;  58 229-237
    Google Scholar
  • 7 Khosla R, Willoughby C P, Jewell D P. Crohn’s disease and pregnancy.  Gut. 1984;  25 52-56
    Google Scholar
  • 8 Birnie G G, McLeod T I, Watkinson G. Incidence of sulphasalazine-induced male infertility.  Gut. 1981;  22 452-455
    Google Scholar
  • 9 O’Morain C, Smethurst P, Dore C J. et al . Reversible male infertility due to sulphasalazine: studies in man and rat.  Gut. 1984;  25 1078-1084
    Google Scholar
  • 10 Toovey S, Hudson E, Hendry W F. et al . Sulphasalazine and male infertility: reversibility and possible mechanism.  Gut. 1981;  22 445-451
    Google Scholar
  • 11 Shaffer J L, Kershaw A, Berrisford M H. Sulphasalazine-induced infertility reversed on transfer to 5-aminosalicylic acid.  Lancet. 1984;  1 1240
    Google Scholar
  • 12 Wu F C, Aitken R J, Ferguson A. Inflammatory bowel disease and male infertility: effects of sulfasalazine and 5-aminosalicylic acid on sperm-fertilizing capacity and reactive oxygen species generation.  Fertil Steril. 1989;  52 842-845
    Google Scholar
  • 13 Dejaco C, Mittermaier C, Reinisch W. et al . Azathioprine treatment and male fertility in inflammatory bowel disease.  Gastroenterology. 2001;  121 1048-1053
    Google Scholar
  • 14 Fielding J F. The relative risk of inflammatory bowel disease among parents and siblings of Crohn’s disease patients.  J Clin Gastroenterol. 1986;  8 655-657
    Google Scholar
  • 15 Monsen U, Brostrom O, Nordenvall B. et al . Prevalence of inflammatory bowel disease among relatives of patients with ulcerative colitis.  Scand J Gastroenterol. 1987;  22 214-218
    Google Scholar
  • 16 Yang H, McElree C, Roth M P. et al . Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews.  Gut. 1993;  34 517-524
    Google Scholar
  • 17 Colombel J F, Grandbastien B, Gower-Rousseau C. et al . Clinical characteristics of Crohn’s disease in 72 families.  Gastroenterology. 1996;  111 604-607
    Google Scholar
  • 18 Lee J C, Lennard-Jones J E. Inflammatory bowel disease in 67 families each with three or more affected first-degree relatives.  Gastroenterology. 1996;  111 587-596
    Google Scholar
  • 19 Polito 2nd  J M, Childs B. et al . Crohn’s disease: influence of age at diagnosis on site and clinical type of disease.  Gastroenterology. 1996;  111 580-586
    Google Scholar
  • 20 Thompson N P, Driscoll R, Pounder R E. et al . Genetics versus environment in inflammatory bowel disease: results of a British twin study.  Bmj. 1996;  312 95-96
    Google Scholar
  • 21 Tysk C, Lindberg E, Jarnerot G. et al . Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking.  Gut. 1988;  29 990-996
    Google Scholar
  • 22 Miller J P. Inflammatory bowel disease in pregnancy: a review.  J R Soc Med. 1986;  79 221-225
    Google Scholar
  • 23 Rogers R G, Katz V L. Course of Crohn’s disease during pregnancy and its effect on pregnancy outcome: a retrospective review.  Am J Perinatol. 1995;  12 262-264
    Google Scholar
  • 24 Agret F, Cosnes J, Hassani Z. et al . Impact of pregnancy on the clinical activity of Crohn’s disease.  Aliment Pharmacol Ther. 2005;  21 509-513
    Google Scholar
  • 25 Wulfeck D, Williams T, Amin A. et al . Crohn’s disease with unusual enterouterine fistula in pregnancy.  J Ky Med Assoc. 1994;  92 267-269
    Google Scholar
  • 26 Brandt L J, Estabrook S G, Reinus J F. Results of a survey to evaluate whether vaginal delivery and episiotomy lead to perineal involvement in women with Crohn’s disease.  Am J Gastroenterol. 1995;  90 1918-1922
    Google Scholar
  • 27 Hoffmann J C, Preiss J C, Autschbach F. et al . Clinical practice guideline on diagnosis and treatment of Crohn’s disease.  Z Gastroenterol. 2008;  46 1094-1146
    Google Scholar
  • 28 Cornish J, Tan E, Teare J. et al . A meta-analysis on the influence of inflammatory bowel disease on pregnancy.  Gut. 2007;  56 830-837
    Google Scholar
  • 29 Fonager K, Sorensen H T, Olsen J. et al . Pregnancy outcome for women with Crohn’s disease: a follow-up study based on linkage between national registries.  Am J Gastroenterol. 1998;  93 2426-2430
    Google Scholar
  • 30 Nielsen O H, Andreasson B, Bondesen S. et al . Pregnancy in Crohn’s disease.  Scand J Gastroenterol. 1984;  19 724-732
    Google Scholar
  • 31 Baiocco P J, Korelitz B I. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome.  J Clin Gastroenterol. 1984;  6 211-216
    Google Scholar
  • 32 Fedorkow D M, Persaud D, Nimrod C A. Inflammatory bowel disease: a controlled study of late pregnancy outcome.  Am J Obstet Gynecol. 1989;  160 998-1001
    Google Scholar
  • 33 Mayberry J F, Weterman I T. European survey of fertility and pregnancy in women with Crohn’s disease: a case control study by European collaborative group.  Gut. 1986;  27 821-825
    Google Scholar
  • 34 Woolfson K, Cohen Z, McLeod R S. Crohn’s disease and pregnancy.  Dis Colon Rectum. 1990;  33 869-873
    Google Scholar
  • 35 Porter R J, Stirrat G M. The effects of inflammatory bowel disease on pregnancy: a case-controlled retrospective analysis.  Br J Obstet Gynaecol. 1986;  93 1124-1131
    Google Scholar
  • 36 Bortoli A, Saibeni S, Tatarella M. et al . Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case-control study.  J Gastroenterol Hepatol. 2007;  22 542-549
    Google Scholar
  • 37 Katz J A. Pregnancy and inflammatory bowel disease.  Curr Opin Gastroenterol. 2004;  20 328-332
    Google Scholar
  • 38 Katz J A, Antoni C, Keenan G F. et al . Outcome of pregnancy in women receiving infliximab for the treatment of Crohn’s disease and rheumatoid arthritis.  Am J Gastroenterol. 2004;  99 2385-2392
    Google Scholar
  • 39 Mahadevan U, Sandborn W J, Li D K. et al . Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California.  Gastroenterology. 2007;  133 1106-1112
    Google Scholar
  • 40 Nielsen O H, Andreasson B, Bondesen S. et al . Pregnancy in ulcerative colitis.  Scand J Gastroenterol. 1983;  18 735-742
    Google Scholar
  • 41 Willoughby C P, Truelove S C. Ulcerative colitis and pregnancy.  Gut. 1980;  21 469-474
    Google Scholar
  • 42 Hanan I M, Kirsner J B. Inflammatory bowel disease in the pregnant woman.  Clin Perinatol. 1985;  12 669-682
    Google Scholar
  • 43 Nicholl M C, Thompson J M, Cocks P S. Stomas and pregnancy.  Aust N Z J Obstet Gynaecol. 1993;  33 322-324
    Google Scholar
  • 44 Boulton R, Hamilton M, Lewis A. et al . Fulminant ulcerative colitis in pregnancy.  Am J Gastroenterol. 1994;  89 931-933
    Google Scholar
  • 45 Watson W J, Gaines T E. Third-trimester colectomy for severe ulcerative colitis. A case report.  J Reprod Med. 1987;  32 869-872
    Google Scholar
  • 46 Anderson J B, Turner G M, Williamson R C. Fulminant ulcerative colitis in late pregnancy and the puerperium.  J R Soc Med. 1987;  80 492-494
    Google Scholar
  • 47 Kornfeld D, Cnattingius S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease--a population-based cohort study.  Am J Obstet Gynecol. 1997;  177 942-946
    Google Scholar
  • 48 Schade R R, Van Thiel D H, Gavaler J S. Chronic idiopathic ulcerative colitis. Pregnancy and fetal outcome.  Dig Dis Sci. 1984;  29 614-619
    Google Scholar
  • 49 Reddy D, Murphy S J, Kane S V. et al . Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes.  Am J Gastroenterol. 2008;  103 1203-1209
    Google Scholar
  • 50 Cappell M S, Colon V J, Sidhom O A. A study at 10 medical centers of the safety and efficacy of 48 flexible sigmoidoscopies and 8 colonoscopies during pregnancy with follow-up of fetal outcome and with comparison to control groups.  Dig Dis Sci. 1996;  41 2353-2361
    Google Scholar
  • 51 Homan W P, Thorbjarnarson B. Crohn disease and pregnancy.  Arch Surg. 1976;  111 545-547
    Google Scholar
  • 52 Caprilli R, Gassull M A, Escher J C. et al . European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations.  Gut. 2006;  55 (Suppl 1) i36-i58
    Google Scholar
  • 53 Brumfitt W, Pursell R. Trimethoprim-sulfamethoxazole in the treatment of bacteriuria in women.  J Infect Dis. 1973;  128 (Suppl 65) 657
    Google Scholar
  • 54 Loebstein R, Addis A, Ho E. et al . Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study.  Antimicrob Agents Chemother. 1998;  42 1336-1339
    Google Scholar
  • 55 Schaefer C, Amoura-Elefant E, Vial T. et al . Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS).  Eur J Obstet Gynecol Reprod Biol. 1996;  69 83-89
    Google Scholar
  • 56 Koren G, Pastuszak A, Ito S. Drugs in pregnancy.  N Engl J Med. 1998;  338 1128-1137
    Google Scholar
  • 57 Beaulieu D B, Ananthakrishnan A N, Issa M. et al . Budesonide induction and maintenance therapy for Crohn’s disease during pregnancy.  Inflamm Bowel Dis. 2009;  15 25-28
    Google Scholar
  • 58 Kallen B, Rydhstroem H, Aberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy.  Obstet Gynecol. 1999;  93 392-395
    Google Scholar
  • 59 Norjavaara E, Verdier M G. Normal pregnancy outcomes in a population-based study including 2,968 pregnant women exposed to budesonide.  J Allergy Clin Immunol. 2003;  111 736-742
    Google Scholar
  • 60 Bermas B L, Hill J A. Effects of immunosuppressive drugs during pregnancy.  Arthritis Rheum. 1995;  38 1722-1732
    Google Scholar
  • 61 Roubenoff de R, Hoyt J, Petri M. et al . Effects of antiinflammatory and immunosuppressive drugs on pregnancy and fertility.  Semin Arthritis Rheum. 1988;  18 88-110
    Google Scholar
  • 62 Willis F R, Findlay C A, Gorrie M J. et al . Children of renal transplant recipient mothers.  J Paediatr Child Health. 2000;  36 230-235
    Google Scholar
  • 63 Blatt J, Mulvihill J J, Ziegler J L. et al . Pregnancy outcome following cancer chemotherapy.  Am J Med. 1980;  69 828-832
    Google Scholar
  • 64 Nicholson H O. Cytotoxic drugs in pregnancy. Review of reported cases.  J Obstet Gynaecol Br Commonw. 1968;  75 307-312
    Google Scholar
  • 65 Mosesso P, Palitti F. The genetic toxicology of 6-mercaptopurine.  Mutat Res. 1993;  296 279-294
    Google Scholar
  • 66 Platzek T, Bochert G. Dose-response relationship of teratogenicity and prenatal-toxic risk estimation of 6-mercaptopurine riboside in mice.  Teratog Carcinog Mutagen. 1996;  16 169-181
    Google Scholar
  • 67 Alstead E M, Ritchie J K, Lennard-Jones J E. et al . Safety of azathioprine in pregnancy in inflammatory bowel disease.  Gastroenterology. 1990;  99 443-446
    Google Scholar
  • 68 Francella A, Dyan A, Bodian C. et al . The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study.  Gastroenterology. 2003;  124 9-17
    Google Scholar
  • 69 Dejaco C, Angelberger S, Waldhoer T. et al . Pregnancy and birth outcome under thiopurine therapy for inflammatory bowel disease.  Gastroenterology. 2005;  128 (Suppl) A12
    Google Scholar
  • 70 Rajapakse R O, Korelitz B I, Zlatanic J. et al . Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease.  Am J Gastroenterol. 2000;  95 684-688
    Google Scholar
  • 71 Kane S. Managing pregnancy in IBD.  Inflamm Bowel Dis Monitor. 2002;  4 2-11
    Google Scholar
  • 72 Armenti V T, Ahlswede K M, Ahlswede B A. et al . National transplantation Pregnancy Registry – outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients.  Transplantation. 1994;  57 502-506
    Google Scholar
  • 73 Bar O z B, Hackman R, Einarson T. et al . Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis.  Transplantation. 2001;  71 1051-1055
    Google Scholar
  • 74 Radomski J S, Ahlswede B A, Jarrell B E. et al . Outcomes of 500 pregnancies in 335 female kidney, liver, and heart transplant recipients.  Transplant Proc. 1995;  27 1089-1090
    Google Scholar
  • 75 Bertschinger P, Himmelmann A, Risti B. et al . Cyclosporine treatment of severe ulcerative colitis during pregnancy.  Am J Gastroenterol. 1995;  90 330
    Google Scholar
  • 76 Kainz A, Harabacz I, Cowlrick I S. et al . Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus.  Transplantation. 2000;  70 1718-1721
    Google Scholar
  • 77 Berthelot J M, De Bandt M, Goupille P. et al . Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature.  Joint Bone Spine. 2009;  76 28-34
    Google Scholar
  • 78 Coburn L A, Wise P E, Schwartz D A. The successful use of adalimumab to treat active Crohn’s disease of an ileoanal pouch during pregnancy.  Dig Dis Sci. 2006;  51 2045-2047
    Google Scholar
  • 79 Mishkin D S, Van Deinse W, Becker J M. et al . Successful use of adalimumab (Humira) for Crohn’s disease in pregnancy.  Inflamm Bowel Dis. 2006;  12 827-828
    Google Scholar
  • 80 Chikanza I C, Petrou P, Chrousos G. et al . Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: immunopathogenetic and therapeutic implications.  Br J Rheumatol. 1993;  32 445-448
    Google Scholar
  • 81 Draca S, Levic Z. The possible role of prolactin in the immunopathogenesis of multiple sclerosis.  Med Hypotheses. 1996;  47 89-92
    Google Scholar
  • 82 Jorgensen C, Picot M C, Bologna C. et al . Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis.  Ann Rheum Dis. 1996;  55 94-98
    Google Scholar
  • 83 Kane S, Lemieux N. The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease.  Am J Gastroenterol. 2005;  100 102-105
    Google Scholar
  • 84 Habal F M, Hui G, Greenberg G R. Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy: safety and clinical course.  Gastroenterology. 1993;  105 1057-1060
    Google Scholar
  • 85 Marteau P, Tennenbaum R, Elefant E. et al . Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules.  Aliment Pharmacol Ther. 1998;  12 1101-1108
    Google Scholar
  • 86 Present D H. How to do without steroids in inflammatory bowel disease.  Inflamm Bowel Dis. 2000;  6 48-57; discussion 58
    Google Scholar
  • 87 Beitins I Z, Bayard F, Ances I G. et al . The transplacental passage of prednisone and prednisolone in pregnancy near term.  J Pediatr. 1972;  81 936-945
    Google Scholar
  • 88 Ost L, Wettrell G, Bjorkhem I. et al . Prednisolone excretion in human milk.  J Pediatr. 1985;  106 1008-1011
    Google Scholar

PD Dr. Britta Siegmund

Medizinische Klinik I (Gastroenterologie/Rheumatologie/Infektiologie), Charité Universitätsmedizin Berlin, Campus Benjamin Franklin

Hindenburgdamm 30

12200 Berlin

Phone: ++ 49/30/84 45 40 39

Fax: ++ 49/30/84 45 40 17

Email: britta.siegmund@charite.de

      >